BiomX
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BiomX and other ETFs, options, and stocks.About PHGE
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively.
PHGE Key Statistics
Stock Snapshot
As of today, BiomX(PHGE) shares are valued at $3.10. The company's market cap stands at 4.92M, with a P/E ratio of -0.11.
As of 2025-12-09, BiomX(PHGE) stock has fluctuated between $2.75 and $5.18. The current price stands at $3.10, placing the stock +12.7% above today's low and -40.2% off the high.
BiomX(PHGE) shares are trading with a volume of 803.5K, against a daily average of 157.68K.
During the past year, BiomX(PHGE) stock moved between $2.75 at its lowest and $22.06 at its peak.
During the past year, BiomX(PHGE) stock moved between $2.75 at its lowest and $22.06 at its peak.
PHGE News
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...
BiomX (PHGE) announced its discontinuation of the ongoing Phase 2b clinical trial of nebulized phage therapy BX004 in patients with CF associated with chronic P...